What is Vera Therapeutics's D&A?

Vera Therapeutics (VERA) reported D&A of $140K in Q1 2026.

How has Vera Therapeutics's D&A changed year-over-year?

Vera Therapeutics's D&A increased by 64.7% year-over-year, from $85K to $140K.

What is the long-term trend for Vera Therapeutics's D&A?

Over 4 years (2021 to 2025), Vera Therapeutics's D&A has grown at a 27.7% compound annual growth rate (CAGR), from $176K to $468K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Vera Therapeutics VERA D&A

D&A at other companies

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Travere Therapeutics, Inc.TVTX

$25.21M+96.9%

Aurinia PharmaceuticalsAUPH

$4.82M-0.8%

Nektar TherapeuticsNKTR

$151K-64.6%

Viridian Therapeutics, Inc.VRDN

$121K+3.4%

ImmunomeIMNM

$603K-1.3%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's D&A?: Vera Therapeutics (VERA) reported D&A of $140K in Q1 2026.
How has Vera Therapeutics's D&A changed year-over-year?: Vera Therapeutics's D&A increased by 64.7% year-over-year, from $85K to $140K.
What is the long-term trend for Vera Therapeutics's D&A?: Over 4 years (2021 to 2025), Vera Therapeutics's D&A has grown at a 27.7% compound annual growth rate (CAGR), from $176K to $468K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.